Loading...
Novel Therapeutic Agents Against Cancer Stem Cells of Chronic Myeloid Leukemia
Chronic myeloid leukemia (CML) is induced by the BCR-ABL oncogene, a product of Philadelphia (Ph) chromosome. The BCR-ABL kinase inhibitor imatinib is a standard treatment for Ph(+) leukemia, and has been shown to induce a complete hematologic and cytogenetic response in most chronic phrase CML pati...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2010
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3136127/ https://ncbi.nlm.nih.gov/pubmed/20184539 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|